Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram Presents at Credit Suisse 29th Annual Virtual Healthcare Conference (Transcript)

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Credit Suisse 29th Annual Virtual Healthcare Conference November 9, 2020 3:30 PM ET Company Participants Doug Ingram - Chief Executive Officer Conference Call Participants Martin Auster - Credit Suisse Martin Auster This is Martin Auster. I am the lead Smid cap Biotech Analyst at Credit Suisse. Thanks for joining us at the 29th Annual Credit Suisse Healthcare Conference. I’ve got Doug Ingram, CEO, along with some members of the Sarepta Therapeutics team. Very happy ...